Parkinson's disease (PD) is an age-related, progressive, complex neurodegenerative disease, which significantly affects quality of life and affects approximately 1% of people over 60 years of age. The disease is characterized behaviorally by motor and non-motor symptoms and pathologically by aggregations of the α-synuclein protein[@b1][@b2]. PD involves both genetic and environmental factors, and associations between hereditary PD and mutations in certain genes have been identified, including *LRRK2*, *PARKIN*, *DJ1*, *ATP13A2*, *VPS35*, *PINK1,* and *SNCA*[@b3][@b4][@b5]. However, these mutations account for only a small percentage of PD cases, and the majority of PD cases are the sporadic form of the disease, indicating that additional genes may also contribute to the risk of PD.

Recently, several genome-wide association studies (GWAS) have identified numerous genes associated with sporadic PD, including *SNCA*, *GBA*, *MAPT*, and *HLA*[@b6][@b7]. In 2012, Pankratz *et al.* identified an association between a polymorphism in Ras-like without CAAX 2 (*RIT2*), rs12456492, and PD risk in a large White population when performing a meta-analysis of GWAS results[@b8]. Several studies have shown results that were similar to those of Pankratz *et al.*[@b9][@b10][@b11]; however, Lin *et al.* found no association between rs12456492 and PD in a Taiwanese population[@b12]. To derive a more precise estimation of the association between rs12456492 and PD in Asian populations, we carried out the current meta-analysis, aiming to study the role of rs12456492 in PD pathogenesis and to explain the possible reasons for the controversial results.

Methods
=======

Search strategy
---------------

Literature searches were performed using PubMed and Embase. The search strategy was based on the following search terms, "Parkinson's disease or PD" and "Ras-like without CAAX 2 or RIT2 or Rin or rs12456492" and "polymorphism or mutation or variation or SNP", with the last report up to June 3, 2015. All eligible studies were retrieved, and their bibliographies were examined for relevant publications.

Inclusion criteria
------------------

The inclusion criteria for studies were as follows: (1) association shown between rs12456492 and PD risk in Asian populations; (2) case-control design; and (3) available phenotype or allele frequencies of rs12456492 in cases and controls. Abstracts from conferences, studies without sufficient data for odds ratios (OR) and 95% confidence intervals (CI), republished or duplicate studies, and reviews were excluded.

Data extraction
---------------

Data from eligible studies were extracted by Yanjun Lu and Wei Liu, according to the above inclusion and exclusion criteria. The following information was collected from each study: the first author, year of publication, country, ethnicity of the sample population, sample size, phenotype distribution, and minor allele frequency (MAF).

Statistical analysis
--------------------

Data were analyzed by STATA software, version 11.0 (STATA Corp., College Station, TX, USA). Hardy Weinberg equilibrium (HWE) in the control group of each study was examined, and P \< 0.05 was considered as departure from HWE. The association between rs12456492 and risk of PD was evaluated by pooled OR and 95% CI. Four genetic models, including the allelic (G vs. A), dominant (GG + AG vs. AA), recessive (GG vs. AG + AA), and additive (GG vs. AA), were used to analyze the association. The significance of the pooled OR was assessed by the Z test, and P \< 0.05 was considered as statistically significant. The Q-test and I^2^ tests were used to investigate the heterogeneity between studies. If P \> 0.10 for the Q-test, or if I^2^ \< 50%, the fixed-effect model was used to calculate the pooled ORs; if P \< 0.10 for the Q-test, or if I^2^ \> 50%, the random-effect model was applied. Sensitivity analysis was carried out by sequentially omitting one study at a time to estimate the stability of the result. Publication bias among studies was determined using Begg's test and Egger's test.

Results
=======

Study selection and characteristics
-----------------------------------

The selection process of studies included in this meta-analysis is shown in [Figure S1](#S1){ref-type="supplementary-material"}. The initial search found 42 studies (PubMed: 33, Embase: 9). Of these, four studies in Embase were also found in PubMed; therefore, 38 total studies were identified. After a careful abstract or full-text review, one review, 30 irrelevant studies, and two articles without sufficient genotype information[@b8][@b13] were excluded. The remaining five studies were selected, and the data were extracted from these. However, a study conducted by Nie *et al.* departed from HWE (P = 0.03), and their data were therefore excluded from further meta-analysis[@b11]. Finally, four studies published between 2013 and 2015 comprising 2017 PD cases and 2010 controls were included in the current meta-analysis[@b9][@b10][@b12][@b14]. Emamalizadeh *et al.* chose an Asian population in Iran[@b10], therefore, all the included four studies were Asian populations. The characteristics and genotypes included in these studies are listed in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}.

Meta-analysis results
---------------------

First, the heterogeneity of rs12456492 in the pooled population was evaluated. The results showed clear heterogeneity in the allelic, recessive, and additive genetic models ([Table 3](#t3){ref-type="table"}). The ORs and 95% CIs in random- and fixed-effect models were calculated according to the values of P~Q~ and I^2^. We found that rs12456492 was significantly associated with an increased risk of PD in the dominant and additive genetic models in the pooled Asian populations (P \< 0.05; [Fig. 1](#f1){ref-type="fig"}).

We performed a stratified analysis by MAF (\>0.5 vs. \<0.5), and the results showed that rs12456492 was significantly associated with PD in all four genetic models in the subgroup with a MAF \< 0.5 ([Table 3](#t3){ref-type="table"}).

Heterogeneity test and sensitivity analysis
-------------------------------------------

Meta-regression was performed to explore the source of heterogeneity, considering the publication year and MAF (\>0.5 vs. \<0.5) as possible covariates. No covariate significantly contributing to the heterogeneity in any genetic model was found ([Table 4](#t4){ref-type="table"}). However, MAF tended to influence the heterogeneity in the allelic and recessive genetic models (P = 0.094, P = 0.091 respectively). In the overall analysis, rs12456492 was not associated with PD risk in the allelic or recessive genetic models, while in the MAF \< 0.05 subgroup, rs12456492 was significantly associated with PD risk in both genetic models. These data suggest that MAF may slightly influence the heterogeneity.

The sensitivity analysis showed that in the allelic and recessive genetic models, after omitting Lin *et al.*'s study, rs1245692 was associated with PD (allelic: OR = 1.27, 95% CI = 1.14--1.40, P = 0.000; recessive: OR = 1.42, 95% CI = 1.17--1.71, P = 0.000). In the additive genetic model, the sensitivity analysis showed that the result was not stable (Liu: OR = 1.33, 95% CI = 0.89--1.98, P = 0.166; Wang: OR = 1.34, 95% CI = 0.89--2.02, P = 0.159; Emamalizadeh: OR = 1.28, 95% CI = 0.90--1.83, P = 0.176). In the dominant genetic model, the sensitivity analysis showed that the result was stable (Liu: OR = 1.21, 95% CI = 1.02--1.41, P = 0.022; Wang: OR = 1.22, 95% CI = 1.04--1.44, P = 0.017; Emamalizadeh: OR = 1.29, 95% CI = 1.10--1.51, P = 0.002; Lin: OR = 1.33, 95% CI = 1.14--1.54, P = 0.000). These data implied that our meta-analysis results were not robust in the allelic, recessive, and additive genetic models but remain stable in the dominant genetic model in Asian populations.

Publication bias
----------------

Publication bias was assessed by Begg's test and Egger's test. A publication bias was found in the dominant genetic model. A trending bias also existed in the recessive and additive models (P = 0.087 and P = 0.070 respectively; [Table 5](#t5){ref-type="table"}). These data indicate that the number of studies analyzed in the current meta-analysis may be insufficient.

Discussion
==========

RIT2 (formerly named Rin) is a member of the Ras superfamily of small guanosine triphosphate binding proteins localized on the plasma membrane. RIT2 is specifically expressed in neurons, and preferentially expressed in the dopaminergic neurons in the substantia nigra (SN)[@b15]. RIT2 binds to calmodulin 1, a phosphorylase kinase, which binds to the products of *SNCA* and *MAPT*, susceptibility genes for PD[@b9]. Furthermore, RIT2 directly interacts with the dopamine transporter and mediates its internalization and functional downregulation via the PKC-regulated pathway[@b16]. In addition, postmortem examination of PD patients found reduced expression of *RIT2* in the SN compared with unaffected controls[@b17]. A meta-analysis conducted by Pankratz *et al.* identified rs12456492 as a novel locus for PD[@b8]. In 2014, Nalls *et al.* performed a large-scale meta-analysis of GWAS data including 13,708 cases and 95,282 controls in a White population. They also identified rs12456492 as a risk locus for PD[@b13]. Taken together, these data suggest that RIT2 may play an essential role in the pathogenesis and development of PD. Several replication studies have investigated the association of rs12456492 and PD risk in different populations; however, the results were controversial. Thus, we have conducted this meta-analysis to explore the pooled effect size of the association between rs12456492 and PD susceptibility in Asian populations.

We investigated the four selected studies carefully. Significant association of rs12456492 with PD risk was found in the pooled Asian population in the dominant and additive genetic models. Stratified analysis by MAF showed a significant association of rs12456492 with PD risk in all four genetic models in the subgroup with MAF \< 0.5. We performed a meta-regression analysis to investigate the source of heterogeneity, although we failed when considering the publication year and MAF. MAF tended to influence the heterogeneity in the allelic and recessive genetic models (P = 0.094, P = 0.091 respectively), as rs12456492 was significantly associated with PD risk in the two genetic models in MAF \< 0.5 subgroup. The sensitivity analysis showed that the association between rs12456492 and PD susceptibility was robust only in the dominant genetic model. However, a publication bias existed in the dominant genetic model, and a trending bias existed in the recessive and additive models. Of the four studies included in the meta-analysis, only Lin *et al.* did not find a significant association between rs12456492 and PD risk. As a negative result might not be as readily accepted for publication as a positive result, this could be a contributing factor to the publication bias that we found in the rs12456492 investigation. These results indicated that the number of studies included in the meta-analysis was insufficient. Our meta-analysis suggested that although a significant association of rs12456492 with PD risk was found in the pooled population in some of the genetic models, the results should nonetheless be applied cautiously due to the instability caused by the limited number of studies and the sample size.

Differential associations of rs12456492 with PD susceptibility between different MAF groups might be due to the varying genetic backgrounds and sample sizes. Data from the PubMed SNP database (<http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=12456492>) showed that the frequency of allele G was 0.375 and 0.339 in Chinese and Japanese populations, respectively. In an Asian population, the highest MAF was 0.5. In the four studies included in the current meta-analysis, three of them had a MAF \< 0.5, while Lin *et al.*'s data had a MAF \> 0.5. The discrepancy of these results might be due to the genetic heterogeneity between different regions, as Lin *et al.*'s study included a Taiwanese population, while two other studies included a Chinese population from mainland China. This suggests that the complex etiology of PD is influenced by both hereditary and environmental factors. Moreover, in the study by Lin *et al.*, both late-onset PD (62%) and early-onset PD (38%) patients were recruited, and the early-onset PD patients had an age of onset of less than 50 years. However, the mean ages of onset in the other three studies was greater than that in the study by Lin *et al.*, and age might have influenced the heterogeneity and association. Due to insufficient data, we did not examine the contribution of age to heterogeneity in our meta-regression analysis. Therefore, experimental research and human studies with larger sample sizes, different ethnicity, and rigorous design are needed to further clarify this association.

Some limitations were present in this meta-analysis. First, only studies published in English were included. Second, the stratified analysis was performed only by MAF, without considering other factors. Third, the sample size was small. Fourth, only Asian populations were analyzed in the current meta-analysis, as the associations had been found in White populations[@b8][@b13]. All of these limitations may lead to bias in our results.

In summary, our meta-analysis suggested that rs12456492 was significantly associated with PD in Asian populations. However, additional studies with larger sample sizes, gene-gene and gene-environment interactions in different countries and ethnic populations may be helpful in providing a more reliable estimation of the association between rs12456492 and PD susceptibility.
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###### Characteristics of four studies included in this meta-analysis.

  Author            Year   Region   Ethnicity   Sample size  
  ---------------- ------ -------- ----------- ------------- -----
  Liu ZH            2015   China      Asian         460       473
  Wang JY           2015   China      Asian         537       517
  Emamalizadeh B    2014    Iran      Asian         520       520
  Lin CH            2013   Taiwan     Asian         500       500

###### Genotype frequencies of rs12456492 in four studies included in this meta-analysis.

  Author            Case   Control   MAF   HWE                              
  ---------------- ------ --------- ----- ----- ----- ----- ------- ------- -------
  Liu ZH            100      225     135   84    212   177   0.462   0.402   0.141
  Wang JY            96      257     184   74    229   214   0.418   0.365   0.317
  Emamalizadeh B    111      247     162   72    265   183   0.451   0.393   0.122
  Lin CH            171      252     77    189   236   75    0.594   0.614   0.925

###### Meta-analysis of rs12456492 polymorphism and risk of PD in Asian populations.

  Genetic comparison    P~Q~    I^2^    Random model 95% CI   P~Z~    Fixed model 95% CI   P~Z~
  -------------------- ------- ------- --------------------- ------- -------------------- -------
  Overall (n = 4)                                                                         
   G vs. A              0.027   67.4%    1.17 (1.00--1.37)    0.050                           
   GG + AG vs. AA       0.310   16.3%                                 1.26 (1.10--1.44)    0.001
   GG vs. AG + AA       0.011   73.3%    1.23 (0.92--1.66)    0.167                           
   GG vs. AA            0.055   60.5%    1.38 (1.03--1.83)    0.030                           
  MAF \< 0.5 (n = 3)                                                                      
   G vs. A              0.986   0.0%                                  1.27 (1.14--1.40)    0.000
   GG + AG vs. AA       0.623   0.0%                                  1.33 (1.14--1.54)    0.000
   GG vs. AG + AA       0.426   0.0%                                  1.42 (1.17--1.71)    0.000
   GG vs. AA            0.849   0.0%                                  1.60 (1.30--1.98)    0.000

###### Meta-regression of rs12456492 polymorphism and risk of PD in Asian populations.

  Genetic comparison      t     P \> \|t\|     95% CI
  -------------------- ------- ------------ -------------
  Publication year                          
   G vs. A              2.38      0.140      −0.12--0.40
   GG + AG vs. AA       1.86      0.205      −0.23--0.58
   GG vs. AG + AA       1.03      0.411      −0.55--0.90
   GG vs. AA            1.60      0.251      −0.40--0.88
  MAF                                       
   G vs. A              −3.03     0.094      −0.77--0.13
   GG + AG vs. AA       −1.62     0.246      −1.14--0.51
   GG vs. AG + AA       −3.09     0.091      −1.21--0.19
   GG vs. AA            −2.70     0.114      −1.55--0.36

###### Publication bias analysis of the meta-analysis.

                             Test             t (95% CI)   P value
  ---------------- ------------------------- ------------ ---------
  G vs. A                 Begg's Test                       1.00
  Egger's test      −0.24 (−237.14--212.55)     0.836     
  GG + AG vs. AA          Begg's Test                       0.308
  Egger's test         5.39 (1.09--9.74)        0.033     
  GG vs. AG + AA          Begg's Test                       0.308
  Egger's test        3.15 (−5.22--33.91)       0.087     
  GG vs. AA               Begg's Test                       0.734
  Egger's test      −3.57 (−155.17--14.53)      0.070     

[^1]: These authors contributed equally to this work.
